Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization

BACKGROUND: Ischemic heart disorders and accumulation of lipids in blood vessels could contribute to angina pectoris. Therefore, the aim of this study was to formulate sublingual tablets containing a novel combination of Atorvastatin calcium (ATOR) and Trimetazidine HCl (TMZ) for efficient treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Atia, Noha N., Tawfeek, Hesham M., Rageh, Azza H., El-Zahry, Marwa R., Abdelfattah, Ahmed, Younis, Mahmoud A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488851/
https://www.ncbi.nlm.nih.gov/pubmed/31061623
http://dx.doi.org/10.1016/j.jsps.2019.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488851/
https://www.ncbi.nlm.nih.gov/pubmed/31061623
http://dx.doi.org/10.1016/j.jsps.2019.02.001

Ejemplares similares